When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the ...

Nanomedicine uses ultra-small particles to deliver drugs directly to the tissues and cells that need them, improving ...

A special group of immune cells known as regulatory T cells, or Tregs for short, became an overnight sensation when a trio of ...

A research team has introduced a novel cancer immunotherapy strategy. This approach involves attaching "fake targets" to ...

This year's Nobel Prize in Physiology or Medicine has been awarded to scientists who elucidated the "brake" mechanism of the ...

In a momentous recognition of groundbreaking research, the Nobel Assembly at the Karolinska Institute in Sweden has awarded the 2025 Nobel Prize in Physiology or Medicine to three distinguished ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment. However, cancer cells have developed immune evasion strategies, leading to poor ...

ALS may be linked to the immune system, which could explain differences in survival and open doors for new treatments.

WEST LAFAYETTE, Ind. — In the march of metastasis, a molecular trail of crumbs guides some cancer cells from the primary tumor to establish new colonies within the body. Blocking the cells’ ability to ...

Eikon Therapeutics, Inc., a late-stage clinical biopharmaceutical company dedicated to integrating advanced engineering with ...

MIT and Harvard scientists have created engineered CAR-NK cells that can hide from the immune system and more effectively destroy cancer. The cells are designed to suppress immune-rejection signals ...

T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...